In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Galmed Pharmaceuticals Ltd.. Trade Record

NASDAQ:GLMD Galmed Pharmaceuticals Ltd. stock gains 6.23% Exit May 1, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart GLMD Apr 27, 2017, priceSeries
About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of a once-daily, oral therapy for the treatment of liver diseases. It is developing Aramchol, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.

Trade Information
Trade Type
LONG
ReliabilityScore™
96.88
Entry Date
Apr 27, 2017
Entry Price
5.14
Sell Date
May 1, 2017
Sell Price
5.46
Net Gain
6.23%
Hold Time
2 Trading Days